Paper Details

  1. Home
  2. Paper Details

Effects of mesalazine combined with bifid triple viable on intestinal flora, immunoglobulin and levels of cal, MMP-9, and MPO in feces of patients with ulcerative colitis.

Author: JiangX-E, YangS-M, ZhangY, ZhouX-J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigated the effects of mesalazine combined with bifid triple viable on intestinal flora, immunoglobulins, and biomarkers like calprotectin, MMP-9, and MPO in patients with ulcerative colitis.
Paper Details　
Original Abstract of the Article :
Ulcerative colitis (UC) commonly occurs in young and middle-aged people and is characterized by frequent attacks and difficult cure. Mesalazine is often applied in the initial treatment of UC, but it can lead to serious adverse effects. Its combination with bifid triple viable could mitigate adverse...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.26355/eurrev_202001_20079

データ提供：米国国立医学図書館（NLM）

Effects of Mesalazine Combined with Bifid Triple Viable

Ulcerative colitis (UC) is a chronic inflammatory bowel disease. This study explored the effects of mesalazine combined with bifid triple viable on the intestinal flora, immunoglobulin levels, and levels of calprotectin, matrix metalloproteinase-9 (MMP-9), and myeloperoxidase (MPO) in the feces of UC patients. The researchers aimed to evaluate the potential benefits of this combination therapy in managing UC.

Mesalazine and Bifid Triple Viable for UC Treatment

The study found that mesalazine combined with bifid triple viable had beneficial effects on the intestinal flora, immunoglobulin levels, and levels of inflammatory markers in UC patients. This suggests that this combination therapy could be a valuable approach for managing UC, potentially mitigating adverse effects and improving patient outcomes.

The Importance of Gut Health in UC

Maintaining a healthy gut microbiome is crucial for managing UC. Lifestyle modifications, such as dietary changes and probiotics, can play a role in promoting gut health and improving UC symptoms.

Dr. Camel's Conclusion

This research, like a oasis in the desert of inflammatory bowel diseases, explores the potential of mesalazine combined with bifid triple viable for managing UC. The study highlights the importance of understanding the gut microbiome and its role in the pathogenesis and management of UC.

Date :
  1. Date Completed 2021-02-12
  2. Date Revised 2021-02-12
Further Info :

Pubmed ID

32017001

DOI: Digital Object Identifier

10.26355/eurrev_202001_20079

Related Literature

Article Analysis
・Effects of mesalamine rectal
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.